from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1617/pykA

LFCtreatmentdescriptionclass of inhibitor

-0.065

Amikacinug/mL Amikacintranslation

0.946

Cap5-10ug/mL Capreomycintranslation

0.218

Rox10-50 ug/mL Roxithromycintranslation

0.767

SM2-5 ug/mL Streptomycintranslation

-1.033

Tet5-10 ug/mL Tetracyclinetranslation

-0.055

Rif0.2-5ug/mL Rifampicintranscription

0.449

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.147

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.135

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.276

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.339

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.014

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.655

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.783

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.060

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.181

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.472

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.979

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.151

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.587

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.795

KCN5-20 ug/mL Potassium cyaniderespiration

0.777

NaN30.2-2 mM Sodium aziderespiration

0.801

Nigericin50 uM Nigericinrespiration

-1.617

TRC10-150 ug/mL Triclosanrespiration

-1.212

TRZ10-25 ug/mL Thioridazinerespiration

-0.502

Valinomycin0.5-10 uM Valinomycinrespiration

1.191

ZnSO42 mM ZnSO4respiration

1.149

menadione6-10 ug/mL Menadionerespiration

-0.004

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.981

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.260

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.374

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.930

NRP_1Non-replicating persistence stage 1dosRassociated

0.485

Amp0.2mg/mL AmpicillincellWall

0.641

Cephalexin20-100 ug/mL CephalexincellWall

0.437

Cerulenin0.32-5 ug/mL CerulenincellWall

0.103

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.028

EMB10-20 ug/mL EthambutolcellWall

0.966

Eta12-40 ug/mL EthionamidecellWall

0.996

INH0.2-0.4 ug/mL IsoniazidcellWall

0.827

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.139

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.076

BZA0.12 mg/mL BenzamidearomaticAmides

-0.315

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.343

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.292

H2O24 mM hydrogen peroxideDNAdamaging

0.108

Levo10 ug/mL LevofloxacinDNAdamaging

0.195

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.301

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.462

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.143

UVUV-irradiationDNAdamaging

-0.376

ARP41-4 ug/mL Antitubercular compound ARP4?

0.323

Antimycin12.5-50 ug/mL Antimycin A?

0.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.602

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.743

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.395

PA8240.2-2 ug/mL PA-824?

-0.035

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.661

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.235

Verapamil50 uM Verapamil?

0.244

mercaptoethanol2 mM 2-Mercaptoethanol?

0.841

methoxatin10-20 ug/mL Methoxatin?